Product Categories
| Country: | China |
|---|---|
| Tel: | 0316-2883536 |
| Mobile: | 19333636468 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 1H-Benzimidazole-5-carboxylic acid, 2-[[[4-[(E)-amino[[(hexyloxy)carbonyl]imino]methyl]phenyl]amino]methyl]-1-methyl- | C24H29N5O4 | 2459303-30-9 | Details |
| benzofuran-6-carboxylic acid（Lifitegrast Impurity 29） | C9H6O3 | 77095-51-3 | Details |
| Dabigatran iMpurity F | C19H20N4O4 | 1642853-67-5 | Details |
| INDEX NAME NOT YET ASSIGNED | C28H28N6O3 | 2518152-88-8 | Details |
| N-Desethyl Vardenafil | C21H28N6O4S | 448184-46-1 | Details |
| Dabigatran iMpurity O | C27H28N6O4 | 948551-71-1 | Details |
| Dabigatran Impurity 29 | C35H43N7O5 | 1610758-21-8 | Details |
| Linagliptin Impurity F | C27H27F3N8O3 | 1673546-62-7 | Details |
| ethyl 3-(2-(((4-(ethoxy(imino)methyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride | C29H33ClN6O4 | 1354727-65-3 | Details |
| Dabigatran Impurity 38 | C30H33N7O5 | 1416446-40-6 | Details |
| β-Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, methyl ester | C26H27N7O3 | 771459-37-1 | Details |
| Dabigatran Etexilate Impurity 67 | C24H29N5O4 | 1848337-06-3 | Details |
| Linagliptin Impurity 51 | C26H21BrN8O2 | 2138392-83-1 | Details |
| (R)-4-Hydroxy-2-pyrrolidone | C4H7NO2 | 62624-29-7 | Details |
| Hydroxyvardenafil | C23H32N6O5S | 224785-98-2 | Details |
| Dabigatran Etexilate Impurity O HCl | C27H30ClN7O3 | 211914-50-0 | Details |
| Dabigatran iMpurity K | C32H38N8O4 | 1580491-16-2 | Details |
| Linagliptin iMpurity E | C25H28N8O2 | 1446263-38-2 | Details |
| Dabigatran Impurity 18 | C21H23N3O4 | 1422435-35-5 | Details |
| Sodium sarcosinate | C3H8NNaO2 | 4316-73-8 | Details |
| (R)-4-Hydroxy-2-pyrrolidone | C4H7NO2 | 22677-21-0 | Details |
| Dabigatran etexilate C5 | C33H39N7O5 | 1416446-45-1 | Details |
| Cyanamide, N,N-dicyano- | C3N4 | 97904-31-9 | Details |
| Ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate | C18H22N4O3 | 212322-56-0 | Details |
| midazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-(2-hydroxyphenyl)-5-methyl-7-propyl- | C15H16N4O2 | 910554-78-8 | Details |
| Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-5,7-dimethyl- | C20H26N6O4S | 224785-72-2 | Details |
| Dabigatran iMpurity G | C24H29N5O4 | 1912458-32-2 | Details |
| Dabigatran Etexilate Impurity X | C25H26N8O2 | 1643377-48-3 | Details |
| Dabigatran Impurity 9 | C19H21N5O2 | 1408238-41-4 | Details |
| Linagliptin impurity 16 | C26H29N9O3 | 1955514-80-3 | Details |
| (S)-2-(tert-butoxycarbonylamino)-3-(3-(methylsulfonyl)phenyl) propanoic acid | C15H21NO6S | 1289646-76-9 | Details |
| GLYCINE ANHYDRIDE | C4H6N2O2 | 106-57-0 | Details |
| Linagliptin Impurity 14 | C25H29N7O4 | 2416949-69-2 | Details |
| β-Alanine, N-[[2-[[[4-[(E)-amino[[[(4-methylpentyl)oxy]carbonyl]imino]methyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester | C34H41N7O5 | 1873316-88-1 | Details |
| β-Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, labeled with tritium | C25H25N7O3 | 1919877-45-4 | Details |
| β-Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester, hydrochloride (1:) | C27H30ClN7O3 | 1187067-70-4 | Details |
| Dabigatran iMpurity D | C34H41N7O5 | 1610758-22-9 | Details |
| Des-(N-2-pyridyl-β-alanine Ethyl Ester) Dabigatran Etexilate 5-Ethyl Carboxylate (Dabigatran IMpurity) | C26H33N5O4 | 1408238-36-7 | Details |
| 4-Aminobenzamidine dihydrochloride | C7H11Cl2N3 | 2498-50-2 | Details |
| Dabigatran Impurity 10 (DABRC-10) | C35H43N7O5 | 1304574-20-6 | Details |
| Vardenafil Impurity 7 | C19H25N5O4S | 1009013-42-6 | Details |
| 9-fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate | C25H33FO6 | 5534-13-4 | Details |
| 4-hydroxy-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazine-2-yl)phenylsulfonic acid | C15H16N4O5S | 910554-77-7 | Details |
| Desethyl Dabigatran Etexilate | C32H37N7O5 | 212321-78-3 | Details |
| oxiracetam impurity III | C6H8N2O2 | 62833-66-3 | Details |
| Vardenafil EP Impurity B | C17H20N4O5S | 437717-43-6 | Details |
| Dabigatran iMpurity L | C27H28N6O4 | 1422435-41-3 | Details |
| Dabigatran etexilate Imp.C | C34H40N6O6 | 1408238-40-3 | Details |
| Dabigatran Etexilate iMpurity C4 | C32H37N7O5 | 1416446-43-9 | Details |
| Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-(2-ethoxyphenyl)-5,7-dimethyl- | C15H16N4O2 | 224789-20-2 | Details |
| oxiracetam impurity VI | C7H11NO4 | 85614-52-4 | Details |
| (R)-4-Hydroxy-2-pyrrolidone | C4H7NO2 | 25747-41-5 | Details |
| Dabigatran Etexilate Impurity B | C25H25N7O3 | 211914-51-1 | Details |
| 3-(pyridin-2-ylamino)propanoic acid | C8H10N2O2 | 104961-64-0 | Details |
| ethyl 3-(2-(chloroMethyl)-1-Methyl-N-(pyridin-2-yl)-1H-benzo[d]iMidazole-5-carboxaMido)propanoate | C20H21ClN4O3 | 1307233-94-8 | Details |
| Dabigatran Etexilate iMpurity H | C19H20N4O3 | 1702936-92-2 | Details |
| Dabigatran Impurity 10 | C21H24N4O3 | 1422435-37-7 | Details |
| Linagliptin N-Acetyl Impurity | C27H30N8O3 | 1803079-49-3 | Details |
| 2,2'-((piperazine-1,4-disulfonyl)bis(2-ethoxy-5,1-phenylene))bis(5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(3H)-one) | C38H46N10O8S2 | 1255919-03-9 | Details |
| Linagliptin Impurity 33 | C38H42N10O4 | 2443735-53-1 | Details |
| VARDENAFIL, DIHYDROCHLORIDE SALT | C22H29N5O4S | 224788-34-5 | Details |
| Dibanzyloxy phosphatecreatinine | C18H20N3O4P | 19208-69-6 | Details |
| Linagliptin Impurity 3 | C19H24N6O2 | 2749409-37-6 | Details |
| oxiracetam impurity IV | C6H9NO4 | 77191-37-8 | Details |
| 1-METHYLHYDANTOIN | C4H6N2O2 | 616-04-6 | Details |
| N,N-DIMETHYL-GUANIDINE | C3H9N3 | 6145-42-2 | Details |
| Dabigatran Etexilate iMpurity O | C35H43N7O5 | 1349500-09-9 | Details |
| Dabigatran iMpurity E | C20H22N4O3 | 1456889-80-7 | Details |
| Dabigatran Impurity p | C32H36N6O6 | 1408238-37-8 | Details |
| Linagliptin Impurity K | C25H29BrN8O2 | 1638744-06-5 | Details |
| ethyl benzofuran-6-carboxylate | C11H10O3 | 1289646-90-7 | Details |
| N-Desethyl-N-Methyl Vardenafil | C22H30N6O4S | 224785-87-9 | Details |
| Vardenafil Impurity 13 | C21H28N6O4S | 2169247-39-4 | Details |
| Dabigatran Impurity 24 | C38H49N7O5 | 2243727-83-3 | Details |
| N-[1-[3-(2-Ethoxyphenyl)-2,5-dihydro-5-oxo-1,2,4-triazin-6-yl]ethyl]acetamide | C15H18N4O3 | 1417529-59-9 | Details |
| Dabigatran Impurity | C34H41N7O5 | 2096992-14-0 | Details |
| 1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-8-(methylamino)-1-[(4-methyl-2-quinazolinyl)methyl]- | C21H21N7O2 | 2468656-63-3 | Details |
| C3-NITRO-4-METHYLAMINO-BENZOYLCHLORIDE | C8H7ClN2O3 | 82357-48-0 | Details |
| INDEX NAME NOT YET ASSIGNED | C21H24N8O2 | 2748491-45-2 | Details |
| Acetylvardenafil | C25H34N6O3 | 1261351-28-3 | Details |
| oxiracetaM related substance ISF3886 | C8H13N3O4 | 120428-80-0 | Details |
| Linagliptin Impurity D | C20H28N6O4 | 666816-91-7 | Details |
| Linagliptin Impurity H | C22H23N7O2 | 1646355-34-1 | Details |
| 1-Methylguanidine hydrochloride | C2H8ClN3 | 21770-81-0 | Details |
| Dabigatran Etexilate Impurity 64 | C9H10N2O3 | 355809-32-4 | Details |
| Dabigatran Etexilate Impurity 82 | C16H18N4O3 | 1771756-20-7 | Details |
| oxiracetam impurity VII | C8H13NO4 | 62613-81-4 | Details |
| 1H-Benzimidazole-5-carboxylic acid, 2-[[(4-cyanophenyl)amino]methyl]-1-methyl-, methyl ester | C18H16N4O2 | 1970195-83-5 | Details |
| Dabigatran Etexilate iMpurity D | C19H20N4O3 | 1422435-40-2 | Details |
| Dabigatran Etexilate iMpurity I | C14H21N3O2 | 255706-13-9 | Details |
| N-[3-AMino-4-(MethylaMino)benzoyl]-N-2-pyridinyl-β-alanine Methyl Ester | C17H20N4O3 | 1369510-38-2 | Details |
| Dabigatran Etexilate Impurity H | C33H39N7O5 | 211915-00-3 | Details |
| 2-QuinazolineMethanol, 4-Methyl- | C10H10N2O | 13535-91-6 | Details |
| Dabigatran Etexilate iMpurity 1 | C35H43N7O5 | 1610758-19-4 | Details |
| Dabigabine mesylate - intermediate 2 | C27H30ClN7O3 | 1223061-75-3 | Details |
| Dabigatran etexilate Impurity R | C34H41N7O5 | 1610758-20-7 | Details |
| Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[2-ethoxy-5-[(4-ethyl-4-oxido-1-piperazinyl)sulfonyl]phenyl]-5-methyl-7-propyl- | C23H32N6O5S | 448184-48-3 | Details |
| Dabigatran Impurity 16 | C26H24N6O3 | 211916-39-1 | Details |
| Dabigatran Impurity 5 | C34H41N7O5 | 2225986-95-6 | Details |
| Dabigatran Impurity 19 | C34H41N7O5 | 2225986-94-5 | Details |
| Clobetasone | C22H26ClFO4 | 54063-32-0 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 | ||||